Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moiety

Add time:07/11/2019    Source:sciencedirect.com

We have developed a new class of PDE10A inhibitor, a pyrazolo[1,5-a]pyrimidine derivative MT-3014 (1). A previous compound introduced was deprioritized due to concerns for E/Z-isomerization and glutathione-adduct formation at the core stilbene structure. We discovered pyrazolo [1,5-a] pyrimidine as a new lead scaffold by structure-based drug design utilizing a co-crystal structure with PDE10A. The lead compound was optimized for in vitro activity, solubility, and selectivity against human ether-á-go-go related gene cardiac channel binding. We observed that MT-3014 shows excellent efficacy in rat conditioned avoidance response test and suitable pharmacokinetic properties in rats, especially high brain penetration.

We also recommend Trading Suppliers and Manufacturers of Methyl 3-chloroimidazo-[1,2-a]pyridine-7-carboxylate (cas 1396554-42-9). Pls Click Website Link as below: cas 1396554-42-9 suppliers

Prev:Preparation of polymer incarcerated gold nanocluster catalysts (PI-Au) and their application to aerobic oxidation reactions of boronic acids, alcohols, and silyl enol ethers
Next:Crystal structure of {N-(2-hydroxyethylamino) ethylsalicylaldiminato]-palladium(II) chloride}: Synthesis, X-ray structure, electrochemistry, DFT and TDDFT studies)